Amgen Inc vs. Black Diamond Therapeutics, Inc. Common Stock
Amgen Inc (AMGN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| AMGN | BDTX | |
|---|---|---|
| Market Cap | $248.97 billion | $113.76 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-42,555,000 |
AMGN leads on 1 of 1 size & scale factors.
Valuation
| AMGN | BDTX | |
|---|---|---|
| Price / Book | — | 1.18 |
AMGN and BDTX split the valuation factors evenly.
Profitability
| AMGN | BDTX | |
|---|---|---|
| Return on Equity | — | -44.29% |
AMGN and BDTX split the profitability factors evenly.
Dividend
| AMGN | BDTX | |
|---|---|---|
| Dividend Yield | 2.19% | — |
AMGN and BDTX split the dividend factors evenly.
Risk & Sentiment
| AMGN | BDTX | |
|---|---|---|
| Short Interest | 1.66% | 2.27% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, BDTX overview, BDTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.